Patents by Inventor Hans-Dieter Klenk

Hans-Dieter Klenk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040122058
    Abstract: The present invention relates to the use of specific compounds for the treatment and/or prophylaxis of inflammatory conditions. Furthermore, the present invention relates to the use of inhibitors for treating viral infections, particularly to the use of MEK inhibitors, especially MEKI inhibitors, for prophylaxis and/or treatment of virally induced hemorrhagic fever and/or hemorrhagic shock syndromes, for the treatment of virally induced TNF-∝ mediated diseases, and for regulating and/or inhibiting of virally induced TNF-∝ production. Furthermore, methods for preventing and/or treating of virally induced hemonrhagic fevers and/or hemorrhagic shock syndromes, for regulating and/or inhibiting virally induced TNF-∝ production, and for the treatment of virally induced TNF-÷ medicated diseases are disclosed together with pharmaccutical compositions useful within said methods.
    Type: Application
    Filed: January 30, 2004
    Publication date: June 24, 2004
    Inventors: Dorian Bevec, Ute Stroher, Hans-Dieter Klenk, Christian Wallasch
  • Patent number: 6358524
    Abstract: Target cell-specific, non-viral vectors for inserting genes into cells, pharmaceuticals composition comprising such vectors, and methods of their use. Target cell-specific, non-viral vectors for inserting at least one gene into cells of an organism, comprising a complex comprising the following components: a) a non-viral carrier for the gene to be inserted, b) a ligand which can bind specifically to the desired target cell, c) a fusion protein for the penetration of the vector into the cytoplasm of the target cell, and d) the gene to be introduced are disclosed. Vectors of this nature are used, for example, in gene therapy.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: March 19, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Hans-Harald Sedlacek, Hans-Dieter Klenk, Thomas Kissel, Rolf Müller
  • Patent number: 5916803
    Abstract: Target cell-specific, non-viral vectors for inserting genes into cells, pharmaceuticals composition comprising such vectors, and methods of their use. Target cell-specific, non-viral vectors for inserting at least one gene into cells of an organism, comprising a complex comprising the following components:a) a non-viral carrier for the gene to be inserted,b) a ligand which can bind specifically to the desired target cell,c) a fusion protein for the penetration of the vector into the cytoplasm of the target cell, andd) the gene to be introducedare disclosed. Vectors of this nature are used, for example, in gene therapy.
    Type: Grant
    Filed: February 13, 1997
    Date of Patent: June 29, 1999
    Assignee: Hoechst Aktiengesellshaft
    Inventors: Hans-Harald Sedlacek, Hans-Dieter Klenk, Thomas Kissel, Rolf Muller